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Zusammenfassung
DasAuftretenvonResistenzengegenvieleFirst-LineAntibiotikaisteine
schwierige Herausforderung, um bakterielle Infektionen erfolgreich zu
behandeln.ZwarsindresistenteBakterienundfolglichderenResistenz-
gene global verteilt, jedoch sind deutliche Unterschiede bezüglich des
Auftretens in verschiedenen geografischen Regionen beobachtet wor-
den. In diesem Artikel werden mögliche sozioökonomische und sozio-
kulturelle Faktoren sowie regionale Unterschiede in Bezug auf das
Auftreten von resistenten Bakterien und ihren dazu gehörigen Resis-
tenzgenen diskutiert. Untersuchungen zeigen, dass sich die wenigen
Studien,diebisherdurchgeführtwordensind,umBeziehungenzwischen
sozioökonomischen sowie soziokulturellen Faktoren und Resistenzen
zu verstehen, bisher auf phänotypische Antibiotikaresistenzen konzen-
triert haben. Daher werden molekular-basierte Studien des menschli-
chen Einflusses auf bakterielle Resistenz und Anpassung benötigt. Wir
schlagen vor, dass die Ergebnisse dieser Studien gekoppelt mit gut
koordinierter, kulturell angemessener Berücksichtigung sozioökonomi-
scher sowie soziokultureller Bedürfnissen notwendig ist, um die Geißel
antimikrobiellerResistenzensowohlinentwickeltenalsauchinEntwick-
lungsländern zu reduzieren.
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Introduction
Antimicrobial resistance is a global emergency of the
highest magnitude. The increasingly limited number of
effectiveantimicrobialmedicationsposesacriticalbarrier
to the successful treatment of bacterial infections [1].
Resistancetomanynewagentsdevelopssoonaftertheir
introductionintoclinicalpracticeandagriculturesettings,
thus reducing their value to human and veterinary medi-
cine [1], [2], [3]. Several studies have demonstrated a
significant association between antimicrobial use and
the emergence of resistance traits on local scales [4],
[5], [6], [7]. However, relationships between the use of
antimicrobials and the development of resistance in dif-
ferent geographical regions are made more complex by
the interplay of socioeconomic and sociocultural factors
[3], [8], [9], [10], [11]. Synergism between these factors
and bacterial evolutionary processes, including gene
transfereventsandmutations,mayexplaintheenormous
variations in the speed at which resistance to antimicro-
bials emerges in different geographical regions.
Socioeconomicandsocioculturalfactors
and the biology of resistance genes
To date, few clinical and public health microbiologists
haveaddressedthepossibleinfluencesofsocioeconomic
and sociocultural factors upon the development and
spread of antibiotic resistance genes. A review of the
documentationofbacterialresistancepatternsindifferent
countries however showed that cultural and economic
factors could be at play in the distribution of bacterial
resistance determinants [10], [11]. A 2005 global epi-
demiological survey for instance, revealed that the
prevalenceofextendedspectrumbeta-lactamase(ESBL)-
producing Klebsiella pneumoniae isolates from patients
in intensive-care units may be decreasing in France
(7.9%), Sweden (3%), the United States (6.1%), Australia
(5%), and Japan (5%), while continuing to increase in
comparatively less wealthy nations elsewhere in Asia
(20–50%), and in Brazil, Colombia, Venezuela, Poland,
Portugal, Turkey and South Africa (30–60%) [6]. Similar
trends were reported for ESBL-producing E. coli isolates
[7]. Although these differences in phenotypic resistance
rates are consistent with the socioeconomic disparities
among these countries [12] it is difficult to establish
causality based on these ecological data. Nevertheless,
this is an important hypothesis that requires close exam-
ination from clinical, public health and agricultural ex-
perts, particularly given the severity and magnitude of
the problem.
Biological Aspects
Higher prevalence of resistance has consistently been
attributed to antibiotic selective pressures and the avail-
ability of transferable resistance genes. Following this
line of thought, one would expect lower prevalence rates
ofESBLresistance(andESBLresistancegenes)inpoorer
populations that do not have broad access to beta-
lactams such as the newer and more expensive ceph-
alosporins that select for ESBL-producers. However,
substrate specificity of ESBLs is not restricted to newer
generation cephalosporins but includes narrower spec-
trumbeta-lactamssuchasampicillin.Thus,theexpected
lower prevalence rates from limited use of agents nor-
mally expected to select for ESBL-producers can be
amplified by the heavy and unregulated use of narrower
spectrum drugs. Similarly, the genetic environments
around most ESBL determinants have been speculated
to induce mobilization of these genes from the chromo-
some to plasmids that carry multiple genes encoding
resistancetomanyantibiotics,includingaminoglycosides,
chloramphenicol,sulfonamides,trimethoprim,andtetra-
cyclines [13]. Recent findings indicate that bacterial
species have only a small barrier to overcome for the ex-
change of a resistance determinant once it has been in-
tegratedintoauxiliarymobileDNA.Thisscenarioperhaps
explainsthehighprevalenceofplasmid-borneESBLgenes
[6].Weshouldofcourseberemindedthatspecificresist-
ance genes can persist even in geographic regions with
nodirectselectivepressuresfromtheuseoftheirrespect-
ive drugs if the genes are linked with other genetic de-
terminantsassociatedwithantimicrobialsthatareheavily
used in the area [14]. Thus, the unorthodox, unregulated
use of cheaper and readily available beta-lactams like
ampicillin,ampicillin-cloxacillincombinations,aminoglyco-
sides,chloramphenicol,sulfonamides,trimethoprim,and
tetracyclines effectively provides an example of social
forces that could influence the co-selection and reported
higherprevalenceofESBL-producinggenesindeveloping
countries like Bolivia, Peru [15], Nigeria [16], Cameroon
[17], India [18], Colombia [19], Puerto Rico [20] and Vi-
etnam [21] compared to developed countries such as
Canada [22], Spain [23], Switzerland [24], France [25]
and the UK [26].
Sociocultural Factors
RecenttrendsinNigeriahighlightthetypeofunorthodox,
sociocultural-influencedantimicrobialusagepatternsthat
may be driving increases in resistance rates and the
spread of resistance genes. In Southwestern Nigeria,
youngfemalecollegestudentsareincreasinglyusingover
thecounterantimicrobialsduringtheirmenstrualperiods
to prevent perceived risks of infections from feminine
sanitary products and to “treat” menstrual symptoms
such as cramps and bloating [27]. The choice of antimi-
crobial varies between ampicillin, ampicillin-cloxacillin
combinations, metronidazole or tetracycline depending
on socioeconomic ranking and other physiological condi-
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pearance of flow, and onset of cramps [27]. Moreover,
due to the strong social stigmas associated with any in-
fections of the female urogenital system, whether they
are sexually transmitted diseases or other unrelated in-
fections, a significant number of female University
dormitoryresidentsareusingoneormoreself-prescribed
antibioticsincombinationwithmiconazoleorclotrimazole
regularlytopreventormanage“toilet”diseases(candidi-
asis)thatareperceivedtobeassociatedwithcommunity
restroomsincampushousing.Theconsequencesofsuch
inappropriate uses of drug compounds include higher
rates of antimicrobial resistance and have been widely
discussed [4], [5], [6], [7].
Socioeconomic Factors
Higher prevalence of obtainable resistance genes and
overall resistance rates in regions such as Africa, the
Caribbean, South Asia and Latin America could also be
influenced by the high burdens on public health systems
as a result of the HIV/AIDS epidemic, Ebola viruses and
other infectious diseases. Several countries in these re-
gions, especially Africa, spend huge percentages of their
public health budgets on epidemics such as HIV at the
expense of other illnesses and needed upgrades of hos-
pital equipment [28].
A case in point is Uganda which spends about $ 1 billion
per year on HIV-related problems out of a total GNP of
about $ 6 billion [29]. Moreover, there are countries
within the African continent that spend more than half of
their national budgets to service external debts while
losing sight of the long term gains and effective interven-
tionsthatcouldbeobtainedfromsurveillanceofantibiotic
resistance, general improvements in community based
sanitary welfare and other previously described public
health interventions [30]. For instance, Niger spends
three times more money servicing its international debt
than on the health and education sector of the economy.
As a result, there are little or no antibacterial
drugs/medications in hospitals because, on average,
annualhealthspendingonthecontinentofAfricaranges
between $ 13 and $ 21 per person and there are simply
not enough funds available to purchase antimicrobials
[28], [31]. In comparison, this equates to approximately
0.3% of the annual per person healthcare expenditures
in North America. In Canada alone, about $ 4,400 was
spent per person in 2005 [32].
However, even when funds are available, glitches in the
organizational machinery of hospitals due to a combina-
tion of factors – such as: 1) lack of active participation
insurveillanceandcontrolofinfections;2)management's
need to save (or reallocate) money; and 3) reductions in
the number of maintenance staff which could lead to
poorer hygiene and cleanliness in patients' rooms – may
increase the risk of drug resistant bacterial outbreaks,
such as multiple antibiotic-resistant Clostridium difficile
hospital outbreaks, which occur in both developed and
developing countries. In fact, these outbreaks have re-
cently become more rampant in Canada. Between 2003
and 2007, outbreaks of multiple antibiotic-resistant C.
difficile have claimed an estimated 2,000 lives in the
provinceofQuebec[33],[34].Someoutbreaksalsohave
occurred in the province of Ontario, which made drastic
cutstoitshealth-carefunding/budgetbetween2000and
2003.Wesuggestthataconsequenceofunderdeveloped
and under-funded systems of surveillance, research,
healthcare and infection control in both developed and
developing countries could be the silent but rapid move-
ment of mobile genetic elements and the reshuffling of
antibiotic resistance genes [35].
Braindrainisanotherproblem.Manymedicalprofession-
alsindevelopingcountrieshavebeenluredawaytobetter
working conditions and salaries in Western countries. As
a consequence, there are less health professionals per
population in developing countries. For example, in
Ethiopia, the physician-to-population ratio is 1:38,619
and the pharmacist-to-population ratio is 1:3,671,327
[36].Unlikepeopleinmanydevelopingcountries,citizens
ofnationswithhigherpercapitaincomesenjoyincreased
access to health professionals which can lead to more
appropriate uses of antimicrobials and a greater variety
of available antibacterial drugs. These two factors inde-
pendently, as well as their interactions, might explain the
lower overall patterns of antimicrobial resistance ob-
served in these high resource countries. However, signi-
ficantly higher rates of drug resistance also have been
observedinresource-depletedmicro-communitieswithin
those high-income nations indicating that other social,
cultural and/or behavioral factors may be influencing
resistancerates.Population-basedstudieshaverevealed
correlations between the incidences of infectious dis-
eases and educational attainment, per capita income
and behavioral patterns [37]. Poor patient compliance
and self-medication (as described above) aided by the
availability of over the counter drugs, are behaviors that
worsen treatment options which are already very limited
[3], [9].
Genetic flexibility and adaptation of
bacteria to changes in the environment
Under the intense selective pressures of antimicrobial
use and abuse, genetic mutations and recombination
events associated with drug resistance are selected
among bacterial populations. The sophistication and
complexity of these resistance mechanisms, as well as
the ease with which they can be disseminated, are in-
verselyrelatedtothelevelofcautionappliedinantimicro-
bial use within a region being studied. Although specific
mechanismsofactionandgenedisseminationarewidely
known and have been analyzed in great detail [38], [39],
[40], the scientific community must keep pace with the
rapidity and flexibility of resistance gene exchanges
between bacterial genomes of the same species or
membersofmixedpopulations.Acomprehensivegenetic
engineering process has evolved which allows bacteria
to remodel, mix and match genes [40] and to integrate
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direct consequence of this reassortment is greater ease
of bacterial genetic mobility. Whether via conjugation,
transduction,ortransformation,geneticmobilizationmay
occur between similar or diverse bacterial genera. This
pool of resistance determinants is distributed across the
bacterial kingdom worldwide. However, there are signifi-
cant variations in the patterns of resistance gene spread
fromregiontoregion,andthereasonsforthesevariations
are not yet clear.
High population densities and poor living and sanitary
conditions are underlying social forces which have been
directly linked with high densities of mixed bacterial
populations [3], within which rapid exchange of mobile
genetic elements can occur. However, additional unap-
preciatedsocioeconomicfactorsdiscussedinthisarticle
may be at play. The potential for unrestricted exchange
of DNA encoding antimicrobial-compromising proteins
constitutes a great challenge for the assurance of thera-
peutic antibacterial drug efficacy. This is a serious public
health concern on both local and global scales.
Suggestions for improvement and
conclusions
In 2001 the World Health Organization published its
globalstrategyforthecontainmentofantimicrobialresis-
tance [30], a landmark position paper that focused inter-
national attention on this crucial problem. The Infectious
Diseases Society of America has recently published its
own excellent guidelines for antimicrobial stewardship
[41]. We applaud these efforts, and concur with many of
their recommended interventions. However, these inter-
ventions have not yet been implemented on a broader
scale – either in industrialized societies or in developing
nations, where many consumers of antibacterial drugs
earn approximately $ 1.00/day. Thus, we should take
into account the major economic impacts of apparently
simple interventions [42]. Worse yet, political corruption
is often endemic in areas that are hardest hit by rising
rates of resistance. Corruption dampens socioeconomic
activities and perpetuates unemployment, illiteracy, and
thecollapseoftransportation,educationandhealthcare
systems [12]. For all of these reasons, we need to design
thoughtfulnon-genericprograms/interventionsaimedat
the containment of resistance that address specific
socioeconomicandsocioculturalfactorsandaccommod-
atethecurrentneedsofspecificpopulations.Theseinter-
ventions should include, but not be limited to, health
communication programs that educate people about the
proper use of antimicrobials.
Wearetroubledbythecurrentstateofknowledgeregard-
ing the global epidemiology of antimicrobial resistance.
Thelittleresearchthathasbeenconductedtounderstand
relationships between socioeconomic and sociocultural
factors and antimicrobial resistance has focused on pat-
terns of phenotypic antibiotic resistance. Yet, there is a
real need for qualitative and quantitative measurements
of human influences upon the molecular biology of bac-
terial resistance and adaptation. If researchers focus
more attention towards understanding the influence of
socioeconomic and sociocultural factors on genotypic
resistance determinants, perhaps we will develop a
clearer understanding of the ways in which our socioeco-
nomicandsocioculturalenvironmentcontributestoshifts
inthemicrobialecologyofantimicrobialresistance.Ifour
social and cultural experiences influence the molecular
adaptation and spread of resistance genes in the micro-
bial world, then precisely which of those experiences
should we seek to change? This information would allow
us to formulate rational, locally-effective interventions to
quell this problem.
Charitableinstitutionsandcentersofhigherlearninghave
begun to emphasize the importance of this type of re-
search. We are encouraged by the University of Washing-
ton’s recent creation of the Department of Global Health
and the Institute for Health Metrics and Evaluation [43].
It remains to be seen whether research from these and
other programs around the world will focus on ways to
containantimicrobialresistancebyexplainingtheimpacts
of human behaviors upon bacterial molecular phenom-
ena.
An intervention which is effective in one part of the world
might be entirely inappropriate elsewhere. We suggest a
more integrated culturally appropriate approach. We
submitthattheescalatingproblemofantimicrobialresis-
tance is not a single human health problem, but a mani-
festation of an array of problems rooted in the complex
evolution of bacteria and greatly influenced by multifa-
ceted sociocultural and socioeconomic factors, as well
asthehumanandveterinaryuseofantimicrobials.Awell-
coordinated and rational response to this global crisis is
clearly overdue.
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